THE COLLABORATION
01
INTERNATIONAL COLLABORATION
This research is part of an international collaboration platform called “Global Infectious Disease Ethics – GLIDE” . The GLIDE collaborative is an initiative of the University of Oxford and Johns Hopkins University, whose goal is to identify and analyze ethical issues arising in infectious disease treatment, research, response, and preparedness, through the lens of global health ethics.
If you want to obtain more information about different activities and GLIDE international collaborative projects, access: https://www.oxjhubioethics.org
Do you want to know other GLIDE collaborative research projects?
Access: https://www.oxjhubioethics.org/research
THE RESEARCH
02
BRIEF INTRODUCTION
Since the outbreak of the Covid-19 pandemic, a formidable amount of scientific information has been produced and published. Based primarily on clinical and epidemiological studies, a series of recommendations on prevention and treatment strategies have been developed by national and international health organizations. Still, many important questions, both in individual and collective care, remain unanswered. Uncertainty is in the order of the day.
Since uncertainties are inherent to health care, the competence to make decisions without solid evidence is extremely important for professionals in the area. And even with the gradual consolidation of evidence for some interventions, physicians can use their professional prerogative for off-label prescription.
Especially in the midst of an international public health emergency, what factors can impact the clinical decision-making process? What is considered evidence by doctors? And what would be the limits and ethical implications of off-label prescription?
THE ETHICAL IMPLICATIONS OF UNCERTAINTY FOR CLINICAL PRACTICE DURING A PANDEMIC:
THE CASE OF COVID-19 AND PHYSICIANS' UNDERSTANDING OF EVIDENCE
INVITATION TO PARTICIPATE IN RESEARCH.
You are being invited to participate in a survey. The title of the research is “THE ETHICAL IMPLICATIONS OF UNCERTAINTY FOR CLINICAL PRACTICE DURING A PANDEMIC: THE CASE OF COVID-19 AND PHYSICIANS' UNDERSTANDING OF EVIDENCE.”
The objective of this research is to understand and analyze the clinical decision process employed by physicians when scientific evidence is inconclusive.
The research instrument is a questionnaire with closed questions. We estimate that it will take you around 20 minutes to respond. To participate, you must be a doctor and work in the State of São Paulo, Brazil.
The principal investigator and responsible for this research is Aluisio MB Serodio, MD PhD, Associate Professor at the Sector of Biotehics, Surgery Department, Escola Paulista de Medicina, Federal University of São Paulo.
GOALS
03
RESEARCH OBJECTIVES
The main objective of this research is to understand how physicians make clinical decisions when the evidence is inconclusive. We intend to analyze how different evidence is interpreted and why physicians who interpret it choose to adhere, or not, to this evidence.
It is also an objective of this collaboration to develop educational materials and promote an international meeting on the subject.
04 MEMBERS
RESEARCH TEAM
Gail Geller
Berman Institute of Bioethics and School of Medicine
Johns Hopkins University, USA
Rachel Riera
Escola Paulista de Medicina
Federal University of São Paulo, Brazil
Irani Gerab
Escola Paulista de Enfermagem
Federal University of São Paulo, Brazil
Aluisio Serodio
Escola Paulista de Medicina
Federal University of São Paulo, Brazil
Angeliki Kerasidou
Ethox Centre, Nuffield Department of Population Health
University of Oxford, UK
Beatriz Thome
Group of Ethics and Covid
World Health Organization
CONTRIBUTORS
Adriana Samudio
Biostatistics
Federal University of São Paulo, Brazil
Tales Marins
Escola Paulista de Medicina
Federal University of São Paulo, Brazil
CONTACT
If you have any questions, comments or suggestions, send an email to: